- Home
- GLSI vs NPT Comparison
GLSI vs NPT Comparison
Compare GLSI & NPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GLSI | NPT |
|---|---|---|
| Founded | 2006 | 2011 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Chemicals |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 123.9M | 112.7M |
| IPO Year | 2020 | 2025 |
Fundamental Metrics
Financial Performance| Metric | GLSI | NPT |
|---|---|---|
| Price | $26.37 | $5.95 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $50.00 | N/A |
| AVG Volume (30 Days) | ★ 719.3K | 72.9K |
| Earning Date | 11-14-2025 | 02-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $797,148,640.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 18.51 |
| 52 Week Low | $7.78 | $3.14 |
| 52 Week High | $32.91 | $9.18 |
Technical Indicators
Market Signals| Indicator | GLSI | NPT |
|---|---|---|
| Relative Strength Index (RSI) | 66.68 | N/A |
| Support Level | $18.54 | N/A |
| Resistance Level | $32.91 | N/A |
| Average True Range (ATR) | 4.63 | 0.00 |
| MACD | 0.35 | 0.00 |
| Stochastic Oscillator | 56.09 | 0.00 |
Price Performance
Historical ComparisonAbout GLSI Greenwich LifeSciences Inc.
Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in 75 percent of breast cancers at low (1+), intermediate (2+), and high (3+ or over-expressor) levels. The combination of GP2 + GM-CSF is called GLSI-100. The company is currently expanding Flamingo-01 into Europe with plans to open up to 150 sites globally.
About NPT Texxon Holding Limited Ordinary shares
Texxon Holding Ltd provides technology-enabled supply chain management services to customers in the plastics and chemical industries in East China. The company operates through two segments: Supply Chain Trading and Plastic Manufacturing. Its services include procurement, logistics, payments, and fulfillment for Chinese SMEs, and all revenue is generated from operations within the People's Republic of China.